Andrew Stewart Plump, Director, President, Research and Development, on August 10, 2026, sold 165,393 shares in Takeda Pharmaceutical (TAK) for $2,828,220. Following the Form 4 filing with the SEC, Plump has control over a total of 1,047,876 American depositary shares of the company, with 766,569 shares held directly and 281,307 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1395064/000149315226037507/xslF345X05/ownership.xml
Andrew J Briggs, Director, on August 10, 2026, sold 9,000 shares in Farmers & Merchants Bancorp (FMAO) for $311,820. Following the Form 4 filing with the SEC, Briggs has control over a total of 60,550 common shares of the company, with 60,550 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/792966/000119312526347238/xslF345X05/ownership.xml
Benjamin G Wolff, Director, on August 11, 2026, sold 56,711 shares in Globalstar (GSAT) for $4,725,981. Following the Form 4 filing with the SEC, Wolff has control over a total of 4,116 voting common shares of the company, with 4,116 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1366868/000136861826000009/xslF345X05/wk-form4_1786570352.xml
Mark T. Walsh, Director, CEO, on August 10, 2026, sold 192,059 shares in Savers Value Village (SVV) for $2,318,265. Following the Form 4 filing with the SEC, Walsh has control over a total of 47,363 common shares of the company, with 47,363 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1883313/000197718826000008/xslF345X05/wk-form4_1786570403.xml